A5039992390- Renal Diseases and Glomerulopathies
- Parasitic Infections and Diagnostics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Chemotherapy-related skin toxicity
- Ovarian cancer diagnosis and treatment
- Cancer Treatment and Pharmacology
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Chronic Kidney Disease and Diabetes
- Platelet Disorders and Treatments
- Transplantation: Methods and Outcomes
- Chemotherapy-induced cardiotoxicity and mitigation
Centre Hospitalier Universitaire de Clermont-Ferrand
2021
Johnson & Johnson (United States)
1997
PURPOSE To determine the efficacy and safety of pegylated-liposomal doxorubicin in patients with AIDS Kaposi's sarcoma (AIDS-KS) who experienced failure standard chemotherapy. METHODS Fifty-three advanced AIDS-KS disease progression or intolerable toxicities while receiving doxorubicin/bleomycin/vincristine (ABV) bleomycin/vincristine (BV) chemotherapy were identified from a cohort then treated doxorubicin. Patients received 20 mg/m2 (Doxil; Sequus Pharmaceuticals, Inc, Menlo Park, CA) every...
Microsporidiosis is an emerging opportunistic infection in renal transplantation (RT) recipients. We aimed to describe its clinical presentation and treatment.We collected microsporidiosis cases identified RT recipients between 2005 2019 six French centers from the Crystal, Divat Astre prospective databases.We report 68 with intestinal microsporidiosis; patients were predominantly male (61.8%), a median age of 58 (46-69) years. Infection occurred at time 3 (0.8-6.8) years posttransplant....